首页 > 市场调查报告书 > 医疗设备

行动医疗

市场调查报告书

商品编码

1654657

全球行动医疗市场 - 2025 至 2033 年

Global Mobile Health Market - 2025-2033

出版日期: 2025年02月13日 | 出版商:

DataM Intelligence | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024 年全球行动医疗市场规模达到 645.3 亿美元，预计到 2033 年将达到 1,955 亿美元，2025-2033 年预测期内的复合年增长率为 13.0%。

行动医疗（mHealth）由于其便利性以及能够弥补医疗保健差距（患者无需亲自前往诊所即可与医生或护理团队会面）而在服务不足的地区越来越受欢迎。穿戴式装置也促进了这一趋势，这些装置将血糖水平和血压等资料直接传输给医生，使他们能够更好地了解患者的日常生活，并根据这些不同的数值制定更个人化的治疗方案。

市场动态：

驱动因素与约束因素

智慧型手机和行动应用程式的使用日益增多

智慧型手机和行动应用程式在医疗保健领域的日益广泛的使用推动了全球行动医疗市场的发展。这些应用程式提供远距会诊、远端病人监控、药物提醒、健身追踪和慢性病管理等服务。对即时健康监测和个人化医疗保健解决方案的需求加速了行动医疗平台的采用。人工智慧、物联网和巨量资料分析等技术进步正在提高这些解决方案的准确性和可用性。政府对行动医疗解决方案的倡议和私人投资预计将推动市场成长。

缺乏监管框架

缺乏监管体係以及资料安全和病患隐私问题给全球行动医疗公司的营运带来了困难。透过行动应用程式收集和分发敏感的健康资料引发了有关资料外洩和非法存取的问题，从而消除了用户信心。标准化的规则有助于透过一致性确保行动医疗解决方案的品质和安全。网路存取不足、数位文盲和昂贵费用等问题也阻碍了行动医疗解决方案的广泛应用。医疗保健提供者不愿迁移到数位平台，进一步阻碍了市场扩张的潜力。

One Medical
Apple
OMADA Health
Omron Healthcare
Medtronic Plc
Samsung Healthcare Solutions
Philips Healthcare
Luma Health
SeekMed
Similar data will be provided for each market player.
Livongo 健康
- 管道产品描述
- 产品关键绩效指标 (KPI)
- 主要活动
- 市场进入时间表
- 产品渗透率
- 销售估计和预测
巴比伦健康
健康
达里奥健康
将为每个市场参与者提供类似的资料。

第 12 章：附录

简介目录

Product Code: HCIT234

The Global Mobile Health Market reached US$ 64.53 billion in 2024 and is expected to reach US$ 195.50 billion by 2033, growing at a CAGR of 13.0% during the forecast period 2025-2033.

Mobile Health (mHealth) is gaining popularity in underserved areas due to its convenience and ability to bridge the healthcare gap by allowing patients to meet with doctors or care teams without physically visiting a clinic. This trend is also facilitated by wearables that transmit data like glucose levels and blood pressure directly to physicians, enabling them to better understand patients' daily lives and create more personalized treatments based on these varying values.

Market Dynamics: Drivers & Restraints

Growing use of Smartphones and Mobile Applications

The global mobile health market is driven by the growing use of smartphones and mobile applications in healthcare. These applications offer services like teleconsultations, remote patient monitoring, medication reminders, fitness tracking, and chronic disease management. The demand for real-time health monitoring and personalized healthcare solutions has accelerated the adoption of mHealth platforms. Technological advancements like AI, IoT, and big data analytics are improving the accuracy and usability of these solutions. Government initiatives and private investments in mobile health solutions are expected to fuel market growth.

Lack of Regulatory Frameworks

Lack of regulatory systems and issues with data security and patient privacy provide difficulties for the worldwide mobile health company operations. Sensitive health data gathering and distribution via mobile apps begs questions about data breaches and illegal access, therefore erasing user confidence. Standardized rules help to ensure mHealth solutions' quality and safety by means of consistency. Widespread adoption of mobile health solutions is also hampered by problems like inadequate internet access, digital illiteracy, and expensive expenses. Further impeding the market's potential for expansion are healthcare providers' resistance to migrate to digital platforms.

Segment Analysis

The global Mobile Health market is segmented based on Service, Application, End User and Region.

Service:

Consultation Services segment is expected to dominate the Mobile Health market share

The consultation services segment holds a major portion of the Mobile Health market share and is expected to continue to hold a significant portion of the Mobile Health market share during the forecast period.

Consultation services are vital in the global mobile health market, offering remote medical guidance, virtual consultations, and real-time patient monitoring. They reduce in-person visits and improve healthcare accessibility. The rise of telemedicine, AI-driven chatbots, and mobile-based health applications enhances patient engagement, enabling timely interventions and personalized treatment plans. Consultation services aid in chronic disease management, mental health support, and preventive care, enhancing healthcare system efficiency and scalability.

For instance, in February 2024, mCURA Mobile Health has launched MediLounge, a premium integrated direct and teleconsultation platform, enhancing patient access to specialists across cities and abroad. The platform, based in A.S. Rao Nagar, Hyderabad, offers pre-assessment services, IoT-enabled instant tests, and teleconsultation with specialists, aiming to revolutionize the Outpatient Department (OPD) sector.

End Users:-

Healthcare Providers segment is the fastest-growing segment in Mobile Health market share

The healthcare providers segment is the fastest-growing segment in the Mobile Health market share and is expected to hold the market share over the forecast period.

Healthcare providers are leading the global mobile health market by utilizing digital platforms to improve patient care and streamline medical operations. They integrate mHealth solutions like remote patient monitoring, telehealth consultations, and mobile-based diagnostics, using electronic health records, wearable health devices, and mobile applications. This approach enhances patient outcomes, reduces costs, and improves access to medical services, especially in remote and underserved areas.

For instance, in December 2024, Healthcare providers are leveraging digital platforms to enhance patient care and streamline medical operations. They integrate mHealth solutions like remote patient monitoring, telehealth consultations, and mobile-based diagnostics, using electronic health records, wearable devices, and mobile applications.

Geographical Analysis

North America is expected to hold a significant position in the Mobile Health market share

North America holds a substantial position in the Mobile Health market and is expected to hold most of the market share due to high smartphone adoption and advanced healthcare infrastructure. The region's well-established healthcare system encourages the integration of mHealth solutions for remote patient monitoring, telemedicine, and chronic disease management. The increasing prevalence of chronic diseases like diabetes, hypertension, and obesity has further fueled the demand for mobile health applications for continuous monitoring and personalized treatment.

For instance, in July 2024, Mobile Health, a digital health and wellness platform, has launched a virtual care solution to address chronic health conditions like diabetes, high blood pressure, musculoskeletal disorders, weight management, depression, anxiety, and prenatal care. The solution offers a science-based approach to prevent these conditions without expensive health insurance claims, enhancing health and well-being.

Moreover, in August 2024, DocGo Inc., a leading provider of technology-enabled mobile health services, has launched a mobile x-ray program in New York City, partnering with MinXray, to provide rapid and accessible chest x-rays for vulnerable populations and help identify active Tuberculosis cases.

Europe is growing at the fastest pace in the Mobile Health market

Europe holds the fastest pace in the Mobile Health market and is expected to hold most of the market share due to rise in the ageing population who are more susceptible to chronic diseases where mobile applications are needed to monitor and manage the conditions like diabetes, cardiovascular diseases etc Moreover, novel app launches by significant key players, increase in healthcare infrastructure and other factors help the region to grow during the forecast period.

For instance, in May 2024, UK healthcare leaders have revealed that it could take up to a decade before patients have equal access to digital healthcare. The research, 'Bridging the digital gap in UK healthcare', reveals that despite 34% of respondents stating it could take 10 years, there has been progress in recent years. NHS staff acknowledge the positive impact of Integrated Care Systems (ICS) on technology adoption, with 98% acknowledging it positively influences technology adoption.

Competitive Landscape

The major global players in the Mobile Health market include GE Healthcare, One Medical, Apple, OMADA Health, Omron Healthcare, Medtronic Plc, Samsung Healthcare Solutions, Philips Healthcare, Luma Health, SeekMed and among others.

Key Developments

In September 2024, Mobile Health Consumer, Inc., a leading provider of digital health solutions, has introduced two programs to address the rising demand for GLP-1 medications and promote long-term success through lifestyle changes. The GLP-1 Prerequisite Program and GLP-1 Lifestyle Support Program aim to encourage healthier habits before, during, and after medication use.
In June 2024, DexCom, a global leader in real-time continuous glucose monitoring for diabetes patients, has announced that its Dexcom G7 Continuous Glucose Monitoring (CGM) System currently connects directly to Apple Watch in the United States, making it the first and only CGM available with Direct to Apple Watch, providing real-time glucose readings on wrists.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global mobile health market report delivers a detailed analysis with 62 key tables, more than 56 visually impactful figures, and 192 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Component & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Service
3.2. Snippet by Application
3.3. Snippet by End User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Growing use of Smartphones and Mobile Applications
- 4.1.2. Restraints
  - 4.1.2.1. Lack of Regulatory Frameworks
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. By Service

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service
- 6.1.2. Market Attractiveness Index, By Service
6.2. Consultation Services*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Fitness & Wellness Solution
6.4. Monitoring
6.5. Diagnostic
6.6. Treatment
6.7. Prevention

7. By Application

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 7.1.2. Market Attractiveness Index, By Application
7.2. Body and Temperature Monitors*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Blood Glucose Monitors
7.4. Cardiac Monitors
7.5. Hemodynamic Monitors
7.6. Neurological Monitors
7.7. Remote Patient Monitoring Devices
7.8. Respiratory Monitors

8. By End User

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 8.1.2. Market Attractiveness Index, By End User
8.2. Healthcare Providers*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Healthcare Consumers
8.4. Public & Private Insurers
8.5. Others

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.6.1. U.S.
  - 9.2.6.2. Canada
  - 9.2.6.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.6.1. Germany
  - 9.3.6.2. U.K.
  - 9.3.6.3. France
  - 9.3.6.4. Spain
  - 9.3.6.5. Italy
  - 9.3.6.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.6.1. Brazil
  - 9.4.6.2. Argentina
  - 9.4.6.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.6.1. China
  - 9.5.6.2. India
  - 9.5.6.3. Japan
  - 9.5.6.4. South Korea
  - 9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

Key Market Players

11.1. GE Healthcare*
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio
  - 11.1.2.1. Product Description
  - 11.1.2.2. Product Key Performance Indicators (KPIs)
  - 11.1.2.3. Historic and Forecasted Product Sales
  - 11.1.2.4. Product Sales Volume
- 11.1.3. Financial Overview
  - 11.1.3.1. Company Revenue's
  - 11.1.3.2. Geographical Revenue Shares
  - 11.1.3.3. Revenue Forecasts
- 11.1.4. Key Developments
  - 11.1.4.1. Mergers & Acquisitions
  - 11.1.4.2. Key Product Development Activities
  - 11.1.4.3. Regulatory Approvals etc.
- 11.1.5. SWOT Analysis
11.2. One Medical
11.3. Apple
11.4. OMADA Health
11.5. Omron Healthcare
11.6. Medtronic Plc
11.7. Samsung Healthcare Solutions
11.8. Philips Healthcare
11.9. Luma Health
11.10. SeekMed
Similar data will be provided for each market player.

Emerging Market Players

11.11. Livongo Health*
- 11.11.1. Pipeline Products Description
- 11.11.2. Product Key Performance Indicators (KPIs)
- 11.11.3. Key Activities
- 11.11.4. Market Entry Timelines
- 11.11.5. Product Penetration Rate
- 11.11.6. Sales Estimation and Projections
11.12. Babylon Health
11.13. Healint
11.14. DarioHealth
Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE